Skip to content

Author

Pengju Xi

We have 1 of 3 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

DBF4B promotes hepatocellular carcinoma progression by regulating CCNA2 and PSMD11 expression

DBF4B holds promise as both a prognostic biomarker and a novel therapeutic target for HCC after functional experiments demonstrated that silencing DBF4B markedly suppressed the proliferative and migratory capabilities of HCC cells.

Bing Dong, Pengju Xi, Guang-Xin Yang et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.